Literature DB >> 24740542

Host endothelial S1PR1 regulation of vascular permeability modulates tumor growth.

Gor Sarkisyan1, Laurie J Gay1, Nhan Nguyen1, Brunhilde H Felding1, Hugh Rosen2.   

Abstract

Understanding vascular growth and maturation in developing tumors has important implications for tumor progression, spread, and ultimately host survival. Modulating the signaling of endothelial G protein-coupled receptors (GPCRs) in blood and lymphatic vessels can enhance or limit tumor progression. Sphingosine 1-phosphate receptor 1 (S1PR1) is a GPCR for circulating lysophospholipid S1P that is highly expressed in blood and lymphatic vessels. Using the S1PR1- enhanced green fluorescent protein (eGFP) mouse model in combination with intravital imaging and pharmacologic modulation of S1PR1 signaling, we show that boundary conditions of high and low S1PR1 signaling retard tumor progression by enhancing or destabilizing neovasculature integrity, respectively. In contrast, midrange S1PR1 signaling, achieved by receptor antagonist titration, promotes abundant growth of small, organized vessels and thereby enhances tumor progression. Furthermore, in vivo S1PR1 antagonism supports lung colonization by circulating tumor cells. Regulation of endothelial S1PR1 dynamically controls vascular integrity and maturation and thus modulates angiogenesis, tumor growth, and hematogenous metastasis.
Copyright © 2014 the American Physiological Society.

Entities:  

Keywords:  PyMT; S1PR1; angiogenesis; breast cancer; metastasis; vasculature

Mesh:

Substances:

Year:  2014        PMID: 24740542      PMCID: PMC4080184          DOI: 10.1152/ajpcell.00043.2014

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  46 in total

1.  Real-time differential labeling of blood, interstitium, and lymphatic and single-field analysis of vasculature dynamics in vivo.

Authors:  Gor Sarkisyan; Stuart M Cahalan; Pedro J Gonzalez-Cabrera; Nora B Leaf; Hugh Rosen
Journal:  Am J Physiol Cell Physiol       Date:  2012-02-22       Impact factor: 4.249

2.  Scaling rules for diffusive drug delivery in tumor and normal tissues.

Authors:  James W Baish; Triantafyllos Stylianopoulos; Ryan M Lanning; Walid S Kamoun; Dai Fukumura; Lance L Munn; Rakesh K Jain
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-11       Impact factor: 11.205

3.  [Immunosuppressive effect of S1P1 receptor agonist FTY720].

Authors:  Wan-Qi Zhou; Hai-Jing Zhang; Jing Jin; Yan Li; Chao Li; Xiao-Guang Chen
Journal:  Yao Xue Xue Bao       Date:  2012-04

4.  S1P(1) receptor modulation with cyclical recovery from lymphopenia ameliorates mouse model of multiple sclerosis.

Authors:  Pedro J Gonzalez-Cabrera; Stuart M Cahalan; Nhan Nguyen; Gor Sarkisyan; Nora B Leaf; Michael D Cameron; Tomoyuki Kago; Hugh Rosen
Journal:  Mol Pharmacol       Date:  2011-10-26       Impact factor: 4.436

5.  The sphingosine-1-phosphate receptor-1 antagonist, W146, causes early and short-lasting peripheral blood lymphopenia in mice.

Authors:  Gema Tarrasón; Mariona Aulí; Sanam Mustafa; Vladislav Dolgachev; Maria Teresa Domènech; Neus Prats; María Domínguez; Rosa López; Nuria Aguilar; Marta Calbet; Mercè Pont; Graeme Milligan; Steven L Kunkel; Nuria Godessart
Journal:  Int Immunopharmacol       Date:  2011-07-26       Impact factor: 4.932

Review 6.  Molecular mechanisms and clinical applications of angiogenesis.

Authors:  Peter Carmeliet; Rakesh K Jain
Journal:  Nature       Date:  2011-05-19       Impact factor: 49.962

Review 7.  HIF-1: upstream and downstream of cancer metabolism.

Authors:  Gregg L Semenza
Journal:  Curr Opin Genet Dev       Date:  2009-11-26       Impact factor: 5.578

8.  S1P1 inhibits sprouting angiogenesis during vascular development.

Authors:  Adi Ben Shoham; Guy Malkinson; Sharon Krief; Yulia Shwartz; Yona Ely; Napoleone Ferrara; Karina Yaniv; Elazar Zelzer
Journal:  Development       Date:  2012-09-05       Impact factor: 6.868

9.  Actions of a picomolar short-acting S1P₁ agonist in S1P₁-eGFP knock-in mice.

Authors:  Stuart M Cahalan; Pedro J Gonzalez-Cabrera; Gor Sarkisyan; Nhan Nguyen; Marie-Therese Schaeffer; Liming Huang; Adam Yeager; Bryan Clemons; Fiona Scott; Hugh Rosen
Journal:  Nat Chem Biol       Date:  2011-03-27       Impact factor: 15.040

Review 10.  Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics.

Authors:  G L Semenza
Journal:  Oncogene       Date:  2009-11-30       Impact factor: 9.867

View more
  9 in total

Review 1.  Crosstalk between cancer cells and blood endothelial and lymphatic endothelial cells in tumour and organ microenvironment.

Authors:  Esak Lee; Niranjan B Pandey; Aleksander S Popel
Journal:  Expert Rev Mol Med       Date:  2015-01-30       Impact factor: 5.600

Review 2.  S1PR1 as a Novel Promising Therapeutic Target in Cancer Therapy.

Authors:  Narges Rostami; Afshin Nikkhoo; Amir Ajjoolabady; Gholamreza Azizi; Mohammad Hojjat-Farsangi; Ghasem Ghalamfarsa; Bahman Yousefi; Mehdi Yousefi; Farhad Jadidi-Niaragh
Journal:  Mol Diagn Ther       Date:  2019-08       Impact factor: 4.074

3.  Inhibition of Sphingosine Phosphate Receptor 1 Signaling Enhances the Efficacy of VEGF Receptor Inhibition.

Authors:  Anthony S Fischl; Xiaoen Wang; Beverly L Falcon; Rowena Almonte-Baldonado; Diane Bodenmiller; Glenn Evans; Julie Stewart; Takako Wilson; Philip Hipskind; Jason Manro; Mark T Uhlik; Sudhakar Chintharlapalli; Damien Gerald; David C Alsop; Laura E Benjamin; Rupal S Bhatt
Journal:  Mol Cancer Ther       Date:  2019-02-20       Impact factor: 6.261

4.  β1-Blockade Prevents Post-Ischemic Myocardial Decompensation Via β3AR-Dependent Protective Sphingosine-1 Phosphate Signaling.

Authors:  Alessandro Cannavo; Giuseppe Rengo; Daniela Liccardo; Andres Pun; Ehre Gao; Alvin J George; Giuseppina Gambino; Antonio Rapacciuolo; Dario Leosco; Borja Ibanez; Nicola Ferrara; Nazareno Paolocci; Walter J Koch
Journal:  J Am Coll Cardiol       Date:  2017-07-11       Impact factor: 24.094

5.  MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells.

Authors:  Suhail Ahmed Kabeer Rasheed; Cui Rong Teo; Emmanuel Jean Beillard; P Mathijs Voorhoeve; Wei Zhou; Sujoy Ghosh; Patrick J Casey
Journal:  Mol Cancer       Date:  2015-03-26       Impact factor: 27.401

6.  Identification and Analysis of Dysfunctional Genes and Pathways in CD8+ T Cells of Non-Small Cell Lung Cancer Based on RNA Sequencing.

Authors:  Xuefang Tao; Xiaotang Wu; Tao Huang; Deguang Mu
Journal:  Front Genet       Date:  2020-05-08       Impact factor: 4.599

Review 7.  Bile Acids and GPBAR-1: Dynamic Interaction Involving Genes, Environment and Gut Microbiome.

Authors:  Piero Portincasa; Agostino Di Ciaula; Gabriella Garruti; Mirco Vacca; Maria De Angelis; David Q-H Wang
Journal:  Nutrients       Date:  2020-11-30       Impact factor: 5.717

8.  Sphingosine-1-phosphate receptor-1 (S1P1) is expressed by lymphocytes, dendritic cells, and endothelium and modulated during inflammatory bowel disease.

Authors:  T Karuppuchamy; E-H Behrens; P González-Cabrera; G Sarkisyan; L Gima; J D Boyer; G Bamias; P Jedlicka; M Veny; D Clark; R Peach; F Scott; H Rosen; J Rivera-Nieves
Journal:  Mucosal Immunol       Date:  2016-04-06       Impact factor: 7.313

9.  Sphingosine-1-Phosphate Receptor 1 Activity Promotes Tumor Growth by Amplifying VEGF-VEGFR2 Angiogenic Signaling.

Authors:  Vijay Avin Balaji Ragunathrao; Mumtaz Anwar; Md Zahid Akhter; Alejandra Chavez; De Yu Mao; Viswanathan Natarajan; Sribalaji Lakshmikanthan; Magdalena Chrzanowska-Wodnicka; Arkadiusz Z Dudek; Lena Claesson-Welsh; Jan K Kitajewski; Kishore K Wary; Asrar B Malik; Dolly Mehta
Journal:  Cell Rep       Date:  2019-12-10       Impact factor: 9.423

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.